Literature DB >> 23564610

Retinopathy of prematurity: a nationwide survey to evaluate current practices and preferences of ophthalmologists.

Mehmet Ali Sekeroglu1, Emre Hekimoglu, Hande Taylan Sekeroglu, Umut Arslan.   

Abstract

PURPOSE: To emphasize the demographic and occupational characteristics of ophthalmologists primarily involved in retinopathy of prematurity (ROP) care and to ascertain their practices and preferences.
METHODS: A questionnaire was sent to all Turkish ophthalmologists known to be primarily involved in ROP. They were asked about personal and occupational characteristics, practices and preferences related to ROP care, and for their proposals related to ROP training.
RESULTS: Seventy questionnaires were sent, of which 63 (90%) were returned. A total of 44 respondents reported performing laser and 13 vitreoretinal surgery. Preferred treatment was transpupillary laser photocoagulation (54.5%), mostly performed in the operating theater (84.1%) under general anesthesia (72.7%). Only 19 (30.2%) reported intravitreal injection of vascular endothelial growth factor inhibitors (anti-VEGF). Ophthalmologists from university hospitals, trained in retina during fellowship, and performing treatment for ROP more commonly performed anti-VEGF injection. Most of them studied ROP after residency and 76.2% think that ROP training during residency is inadequate for clinical practice.
CONCLUSION: This survey reveals considerable variation among Turkish ROP specialists regarding ROP care. The survey data are critical in order to develop quality improvement and help in planning more effective future programs for ROP care in terms of training.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23564610     DOI: 10.5301/ejo.5000272

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  4 in total

1.  Assessment of Outcomes With a Sedation Protocol During Laser Photocoagulation in Preterm Infants With Retinopathy of Prematurity.

Authors:  Jennifer F Dannelley; Peter N Johnson; Michael P Anderson; Kari Oestreich; R Michael Siatkowski; Jamie L Miller
Journal:  J Pediatr Pharmacol Ther       Date:  2018 Sep-Oct

2.  Sedation Protocol During Bevacizumab Intravitreal Injection in Preterm Infants With Retinopathy of Prematurity.

Authors:  Jamie L Miller; Peter N Johnson; Kari Harkey; R Michael Siatkowski
Journal:  J Pediatr Pharmacol Ther       Date:  2018 Jan-Feb

3.  Low dose fentanyl infusion versus 24% oral sucrose for pain management during laser treatment for retinopathy of prematurity-an open label randomized clinical trial.

Authors:  Amanpreet Sethi; M Jeeva Sankar; Srikanth Kulkarni; Anu Thukral; Parijat Chandra; Ramesh Agarwal
Journal:  Eur J Pediatr       Date:  2019-11-15       Impact factor: 3.183

4.  Deep Learning Algorithm for Automated Diagnosis of Retinopathy of Prematurity Plus Disease.

Authors:  Zachary Tan; Samantha Simkin; Connie Lai; Shuan Dai
Journal:  Transl Vis Sci Technol       Date:  2019-12-02       Impact factor: 3.283

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.